Jacobs Bruce N.
SEC insider (Form 3/4/5 filer). CIK 0001821074. Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR). 26 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in WATERTOWN, MA.
Companies Jacobs Bruce N. has filed insider reports for
- Kymera Therapeutics, Inc. (KYMR): Officer, Chief Financial Officer
Jacobs Bruce N.
CIK: 0001821074
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kymera Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect3.2K shares at avg. $117.70$377K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect6.2K shares at avg. $116.99$720K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect4.1K shares at avg. $114.19$469K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect8K shares at avg. $115.82$923K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.7K shares at avg. $111.57$190K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.5K shares at avg. $110.54$166K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect61.4K shares at avg. $5.33$327K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.1K shares at avg. $112.79$124K - Jun 30, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect51.4K shares at avg. $114.77$5.9M - Jun 2, 2026KYMR
Kymera Therapeutics, Inc.
ExerciseDirect12.7K shares at avg. $2.08$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 3,200 | $117.70 | $376,649 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 6,153 | $116.99 | $719,862 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 4,110 | $114.19 | $469,311 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 7,971 | $115.82 | $923,178 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,700 | $111.57 | $189,664 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,500 | $110.54 | $165,810 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 61,378 | $5.33 | $327,145 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,100 | $112.79 | $124,067 | Direct |
| Jun 30, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 51,375 | $114.77 | $5,896,288 | Direct |
| Jun 2, 2026 | KYMR Kymera Therapeutics, Inc. | Exercise | 12,653 | $2.08 | $26,318 | Direct |
1-10 of 26 transactions